We are live on ! Find out more
Geode Capital Management

Geode Capital Management Portfolio holdings

AUM $1.61T
1-Year Est. Return 30.72%
 

Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.

This Fund
S&P 500
This Quarter Est. Return
+9.83%
1 Year Est. Return
+30.72%
3 Year Est. Return
+105.46%
5 Year Est. Return
+141.95%
10 Year Est. Return
+548.24%
AUM
$851B
AUM Growth
+$80.9B
Cap. Flow
+$19.9B
Cap. Flow %
2.34%
Top 10 Hldgs %
25.93%
Holding
4,889
New
83
Increased
3,362
Reduced
611
Closed
132

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$1.18B
2
AAPL icon
Apple
AAPL
+$1.11B
3
AVGO icon
Broadcom
AVGO
+$562M
4
AMZN icon
Amazon
AMZN
+$553M
5
PANW icon
Palo Alto Networks
PANW
+$485M

Sector Composition

Rank Sector Weight
1 Technology 28.24%
2 Healthcare 13.33%
3 Financials 12.09%
4 Consumer Discretionary 10.85%
5 Industrials 9.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EPIX
4501
DELISTED
ESSA Pharma
EPIX
$51.4K ﹤0.01%
19,039
ASST icon
4502
Strive Inc
ASST
$1B
$51.2K ﹤0.01%
+296
New +$36.6K
BLRX
4503
BioLineRX
BLRX
$11.7M
$51.1K ﹤0.01%
801
MGRM
4504
DELISTED
Monogram Orthopaedics
MGRM
$50.6K ﹤0.01%
+12,719
New +$65.8K
MIST icon
4505
Milestone Pharmaceuticals
MIST
$143M
$50.1K ﹤0.01%
17,576
BLIN icon
4506
Bridgeline Digital
BLIN
$14.7M
$50K ﹤0.01%
42,401
SILO icon
4507
Silo Pharma
SILO
$4.8M
$49.8K ﹤0.01%
1,636
TPHS
4508
DELISTED
Trinity Place Holdings Inc.com
TPHS
$49.8K ﹤0.01%
92,255
XNET
4509
Xunlei
XNET
$360M
$49K ﹤0.01%
24,768
SJ icon
4510
Scienjoy Holding
SJ
$42.3M
$48.9K ﹤0.01%
17,909
KTTA icon
4511
Pasithea Therapeutics
KTTA
$14.8M
$48.1K ﹤0.01%
4,912
TMBR
4512
DELISTED
Timber Pharmaceuticals, Inc.
TMBR
$48.1K ﹤0.01%
19,799
JAGX icon
4513
Jaguar Health
JAGX
$5.11M
$47.8K ﹤0.01%
+2
New +$59K
KBNT
4514
DELISTED
Kubient, Inc. Common Stock
KBNT
$47.6K ﹤0.01%
86,626
MHUA
4515
DELISTED
Meihua International Medical Technologies
MHUA
$46.9K ﹤0.01%
+168
New +$59.3K
DERM icon
4516
Journey Medical
DERM
$178M
$46.9K ﹤0.01%
29,494
GGE
4517
DELISTED
Green Giant Inc. Common Stock
GGE
$46.9K ﹤0.01%
20,468
CRDL
4518
Cardiol Therapeutics
CRDL
$139M
$46.7K ﹤0.01%
52,435
BNKK
4519
Bonk Inc
BNKK
$7.96M
$46.6K ﹤0.01%
3,120
IBIO icon
4520
iBio
IBIO
$69.1M
$46.5K ﹤0.01%
3,814
VFF icon
4521
Village Farms International
VFF
$242M
$46.4K ﹤0.01%
77,462
CGEN icon
4522
Compugen
CGEN
$220M
$46.3K ﹤0.01%
40,579
+13,409
+49% +$11.7K
VRME icon
4523
VerifyMe
VRME
$9.17M
$45.5K ﹤0.01%
32,952
TCON
4524
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
$45.3K ﹤0.01%
7,791
DMK
4525
DELISTED
DMK Pharmaceuticals Corporation Common Stock
DMK
$45.3K ﹤0.01%
18,947
-5
-0% -$21

Similar funds

Geode Capital Management's Q2 2023 Portfolio in Review

As of Q2 2023, Geode Capital Management held 4,889 positions worth $851B, up 11% from $770B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Trading was light in Q2 2023: portfolio turnover was 4.4%. Geode Capital Management opened 83 new positions and exited 132, leaving the 4,889-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 26% a quarter earlier, followed by Healthcare and Financials.

  • Geode Capital Management's largest Q2 2023 buy was Coupang: 4,567,454 shares worth $79.5M.
  • Geode Capital Management added most to Microsoft in Q2 2023, an estimated $1.18B increase.
  • Geode Capital Management's biggest Q2 2023 reduction was Procter & Gamble, cutting an estimated $246M.
  • Geode Capital Management fully exited Evoqua Water Technologies Corp. Common Stock in Q2 2023, selling an estimated $111M.
  • Geode Capital Management's ten largest holdings make up 26% of its $851B portfolio in Q2 2023.
  • Geode Capital Management opened 83 new positions and closed 132 in Q2 2023.
  • Geode Capital Management's portfolio value rose 11% quarter-over-quarter to $851B.

Based on Geode Capital Management's 13F filing for Q2 2023, filed 11 Aug 2023.